McDonald’s: E. Coli Continues To Infect Results; Analysts Expect Value Offerings, Marketing To Drive Performance

McDonald’s continued to edge higher in early trading on Tuesday, despite the company reporting a decline in fourth-quarter revenues.

Latest Ratings for MCD

Date Firm Action From To
Mar 2022 Northcoast Research Downgrades Buy Neutral
Jan 2022 Barclays Maintains Overweight
Jan 2022 Keybanc Maintains Overweight

View More Analyst Ratings for MCD

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *